Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Oaktree Acquisition III Life Sciences Gross Margin 2025-2024 | OACC

Current and historical gross margin for Oaktree Acquisition III Life Sciences (OACC) over the last 10 years. The current gross profit margin for Oaktree Acquisition III Life Sciences as of September 30, 2024 is %.
  
Oaktree Acquisition III Life Sciences Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
Sector Industry Market Cap Revenue
$0.224B $0.000B
Oaktree Acquisition Corp. III Life Sciences is a blank check company. It formed for the purpose of entering into a combination with one or more businesses or entities. Oaktree Acquisition Corp. III is based in LOS ANGELES.
Stock Name Country Market Cap PE Ratio
PicoCELA (PCLA) Japan $0.173B 0.00
Aduro Clean Technologies (ADUR) Canada $0.156B 0.00
Range Capital Acquisition (RANG) United States $0.140B 0.00
Tavia Acquisition (TAVI) $0.139B 0.00
CO2 Energy Transition (NOEM) $0.095B 0.00
Leishen Energy Holding (LSE) China $0.089B 0.00
YHN Acquisition I (YHNA) $0.081B 0.00
Youxin Technology (YAAS) $0.065B 0.00
YSX Tech (YSXT) China $0.062B 0.00
New Century Logistics (BVI) (NCEW) Hong Kong, SAR China $0.026B 0.00
Hong Kong Pharma Digital Technology Holdings (HKPD) $0.019B 0.00
Sky Quarry (SKYQ) $0.016B 0.00
Flowco Holdings (FLOC) $0.000B 0.00